EXEL SCHEDULE 13G: SEC filing
Farallon Capital Management, L.L.C. and affiliated individuals
Filed with the SEC on · accession 0000908834-26-000516
EXEL filed a SCHEDULE 13G (schedule 13g) with the SEC on Nov 9, 2026. Farallon Capital Management, L.L.C. and affiliated individuals filed a Schedule 13G disclosing beneficial ownership of 14,694,910 shares of Exelixis, Inc. common stock, representing approximately 5.1% of the class. The stock moved +3.1% by the first close after the filing.
Summary of the filing
Farallon Capital Management, L.L.C. and affiliated individuals filed a Schedule 13G disclosing beneficial ownership of 14,694,910 shares of Exelixis, Inc. common stock, representing approximately 5.1% of the class. The filing is a passive investment disclosure under Rule 13d-1(b).
Key details
How EXEL stock reacted
Close before
$69.57
Nov 6, 2026
First close after
+3.12%
$71.74
5 trading days
—
Since filing
+1.45%
$70.58
✦ Ask GOAX AI about this filing — what it means for EXEL, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for EXEL?
Click hereFrequently asked questions
What did EXEL file with the SEC on Nov 9, 2026?
EXEL filed a SCHEDULE 13G (SEC filing). Farallon Capital Management, L.L.C. and affiliated individuals filed a Schedule 13G disclosing beneficial ownership of 14,694,910 shares of Exelixis, Inc. common stock, representing approximately 5.1% of the class. The filing is a passive investment disclosure under Rule 13d-1(b).
How do I read a SCHEDULE 13G?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G (schedule 13g): A report the company filed with the SEC (the US market regulator).
How did EXEL stock react to this filing?
EXEL closed at $69.57 before the filing and $71.74 on Nov 9, 2026 (+3.12%).
Other EXEL SEC filings
- SCHEDULE 13D/A · Activist campaignNov 9, 2026
- 10-Q · SEC filingOct 29, 2026
- 8-K · SEC filingOct 29, 2026
- 8-K · Fda approvalSep 11, 2026
- 8-K · Regulatory actionAug 31, 2026
- SCHEDULE 13D/A · Activist campaignAug 14, 2026
- SCHEDULE 13G/A · SEC filingAug 12, 2026
- 10-Q · SEC filingAug 5, 2026
- 8-K · SEC filingAug 5, 2026
- 144 · Insider sale plannedJun 1, 2026
Get alerts when EXEL files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days